| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:1962.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
Institute of Biomedical Sciences, Academia Sinica (H.L., T-N.L. W-M.C., G-M.N., P-H.T., S-F.C., J-J.C., S-K.S., J-Y.L., C-W.W.), Taipei, Taiwan; Graduate Institute of Life Sciences, National Defense Medical Center (H.L.), Taipei, Taiwan; and Vascular Biology Research Center, Institute of Molecular Medicine and Division of Hematology, University of TexasHouston Health Science Center (K.K.W.).
Correspondence to Dr Kenneth K. Wu, University of Texas Health Science Center at Houston, 6431 Fannin St, Houston, TX 77030 (E-mail Kenneth.K.Wu{at}uth.tmc.edu) or to Dr Teng-Nan Lin, Institute of Biomedical Sciences, 128 Academy Rd, Section 2, Taipei, Taiwan (E-mail bmltn@IBMS.sinica.edu.tw).
Background We tested the hypothesis that bicistronic cyclooxygenase-1 (COX-1)/prostacyclin synthase (PGIS) and COX-1 gene transfer reduce cerebral infarct volume by augmenting synthesis of protective prostaglandins.
Methods and Results We infused into lateral ventricle of a rat stroke model recombinant adenoviruses (rAd) containing COX-1 (Adv-COX-1), COX-1 and PGIS (Adv-COX-1/PGIS), or Adv-PGK control vector, and we determined COX-1 and PGIS protein and eicosanoid levels and infarct volume. COX-1 and PGIS proteins were increased in a time-dependent manner. Adv-COX-1/PGIS infusion selectively augmented prostacyclin levels, with reduction of other eicosanoids in ischemic cortex and a significant reduction of infarct volume, even when the rAd was administered 5 hours after ischemia. Infusion of Adv-COX-1 also increased prostacyclin, suppressed leukotriene levels, and achieved a similar degree of cerebral protection. Its neuroprotection was abrogated by treatment with a selective COX-1 inhibitor.
Conclusions COX-1/PGIS and COX-1 gene transfer reduce cerebral infarct volume by augmenting prostacyclin and suppressing leukotriene productions. COX-1based gene transfer has potential for treating ischemic stroke.
Key Words: prostaglandins genes stroke ischemia gene therapy
This article has been cited by other articles:
![]() |
H. Lin, C.-C. Hou, C.-F. Cheng, T.-H. Chiu, Y.-H. Hsu, Y.-M. Sue, T.-H. Chen, H.-H. Hou, Y.-C. Chao, T.-H. Cheng, et al. Peroxisomal Proliferator-Activated Receptor-{alpha} Protects Renal Tubular Cells from Doxorubicin-Induced Apoptosis Mol. Pharmacol., November 1, 2007; 72(5): 1238 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Liou, S. Lee, D. Ghelani, N. Matijevic-Aleksic, and K. K. Wu Protection of Endothelial Survival by Peroxisome Proliferator-Activated Receptor-{delta} Mediated 14-3-3 Upregulation Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1481 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, A. Patzer, T. Herdegen, P. Gohlke, and J. Culman Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats FASEB J, June 1, 2006; 20(8): 1162 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-N. Lin, W.-M. Cheung, J.-S. Wu, J.-J. Chen, H. Lin, J.-J. Chen, J.-Y. Liou, S.-K. Shyue, and K. K. Wu 15d-Prostaglandin J2 Protects Brain From Ischemia-Reperfusion Injury Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 481 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-C. Chang, C.-J. Huang, K. Tam, S.-F. Chen, K. T. Tan, M.-S. Tsai, T.-N. Lin, and S.-K. Shyue Stabilization of Hypoxia-inducible Factor-1{alpha} by Prostacyclin under Prolonged Hypoxia via Reducing Reactive Oxygen Species Level in Endothelial Cells J. Biol. Chem., November 4, 2005; 280(44): 36567 - 36574. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Hsieh, W.-Y. Liang, S.-K. Tsai, and C.-S. Wong Intrathecal Ketorolac Pretreatment Reduced Spinal Cord Ischemic Injury in Rats Anesth. Analg., April 1, 2005; 100(4): 1134 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Salzberg-Brenhouse, E.-Y. Chen, D. F. Emerich, S. Baldwin, K. Hogeland, S. Ranelli, D. Lafreniere, B. Perdomo, L. Novak, T. Kladis, et al. Inhibitors of Cyclooxygenase-2, but Not Cyclooxygenase-1 Provide Structural and Functional Protection against Quinolinic Acid-Induced Neurodegeneration J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 218 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ospina, S. P. Duckles, and D. N. Krause 17{beta}-Estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H241 - H250. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |